Does Octreotide Acetate Interact with Insulin Human?
CDI records a major classification for Octreotide Acetate and Insulin Human. The stored summary is: Octreotide inhibits insulin secretion, requiring monitoring and adjustment of anti-diabetic treatment and blood glucose levels. The mechanism involves octreotide inhibits insulin secretion. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Insulin Human Class
- Insulin
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Octreotide inhibits insulin secretion
What To Tell Your Doctor or Pharmacist
If you are taking Octreotide Acetate and your doctor is considering prescribing Insulin Human (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider